FierceBiotechFierceBiotechResearchFierceBiotechITFierceVaccinesFiercePharmaFiercePharmaManufacturing   FierceHealthcare

Free Newsletter

About | View Sample | Privacy
Related Topics >> Pfizer | drug safety | FDA warning | Chantix

Truckers on Chantix can't be licensed

Tools

Trucking regulators have joined the FAA in banning Pfizer's stop-smoking drug among its drivers. The Federal Motor Carrier Safety Administration yesterday said Chantix patients shouldn't be qualified for trucking licenses while using the med. Yesterday, you'll recall, the FAA told pilots and air traffic controllers they couldn't take Chantix, either.

Why now? The Institute for Safe Medication Practices, a watchdog group, issued a report linking Chantix not only to psychiatric side effects already identified, but to a list of other safety problems. Including accidents--which is what makes the transportation folks nervous. The report explicitly stated that people operating heavy machinery might want to think twice before taking the drug.

Pfizer has taken a rational approach to the report, pointing out that millions of people around the world have used Chantix. In that large a population, even the "infrequent" or "rare" effects listed on the drug's label are likely to show up repeatedly. Plus, as the WSJ Health Blog points out, smoking itself is a major risk. If you can't quit any other way, maybe Chantix's benefits outweigh the risks.

Some doctors appear to be taking that line, saying they're prescribing Chantix, but only to people who've already tried other ways to quit, such as the nicotine patch. That's one reason why new scrips have fallen by a third since February's FDA warning, and Wall Street analysts are expecting big declines in sales over time. Not good news for Pfizer, which counted Chantix among its few recent success stories. But that's another article for another day.

- see the WSJ story
- check out the WSJ Health Blog item

Related Articles:
Chantix side-effects news prompts FAA ban
Chantix scrips drop 5% on FDA alert
FDA: Chantix may pose psych risks
FDA gets 5,000 Chantix complaints
'Erratic' behavior triggers Chantix probe


SHARE
WITH:
Email Twitter Facebook LinkedIn StumbleUpon
Get Your FREE FiercePharma Email Newsletter:
Be the first to comment
More stories about Pfizer   drug safety   FDA warning   Chantix  

Comments

Post new comment

The content of this field is kept private and will not be shown publicly.

More information about formatting options

To combat spam, please enter the code in the image.